Skip to main content
. 2019 May 6;181(3):474–482. doi: 10.1111/bjd.17873

Table 1.

Patient demographics of first all‐time registered BCC and cSCC, England 2013–15

Patient demographics of first registered tumour First BCC, n = 268 565 First cSCC n = 76 977
Male, n = 144 680 Female, n = 123 885 Male, n = 48 254 Female, n = 28 723
Age (years)
Median (IQR) 72 (63–79) 71 (60–80) 78 (71–84) 80 (71–87)
0–29 464 (0·3) 641 (0·5) 30 (0·1) 26 (0·1)
30–39 2229 (1·5) 3066 (2·5) 123 (0·3) 98 (0·3)
40–49 7685 (5·3) 9680 (7·8) 655 (1·4) 489 (1·7)
50–59 16 660 (11·5) 16 148 (13·0) 2117 (4·4) 1491 (5·2)
60–69 35 487 (24·5) 27 893 (22·5) 7352 (15·2) 3930 (13·7)
70–79 46 551 (32·2) 33 990 (27·4) 16 158 (33·5) 7735 (26·9)
80–89 30 631 (21·2) 25 913 (20·9) 17 822 (36·9) 10 385 (36·2)
90+ 4973 (3·4) 6554 (5·3) 3997 (8·3) 4569 (15·9)
Ethnicity
White 97 418 (67·3) 80 690 (65·1) 43 283 (89·7) 25 226 (87·8)
Mixed 63 (0·0) 69 (0·1) 29 (0·1) 22 (0·1)
Indian /other Asian background 108 (0·1) 114 (0·1) 73 (0·2) 50 (0·2)
Afro‐Caribbean/other black background 57 (0·0) 61 (0·0) 42 (0·1) 38 (0·1)
Chinese 22 (0·0) 23 (0·0) 7 (0·0) 8 (0·0)
Other ethnic group 402 (0·3) 371 (0·3) 169 (0·4) 96 (0·3)
Unknown 46 610 (32·2) 42 557 (34·4) 4651 (9·6) 3283 (11·4)
Deprivation quintiles
1 (least deprived) 40 366 (27·9) 32 572 (26·3) 12 792 (26·5) 7096 (24·7)
2 37 363 (25·8) 31 004 (25·0) 12 451 (25·8) 7064 (24·6)
3 30 101 (20·8) 26 108 (21·1) 10 200 (21·1) 6295 (21·9)
4 21 915 (15·1) 20 045 (16·2) 7642 (15·8) 4825 (16·8)
5 (most deprived) 14 935 (10·3) 14 156 (11·4) 5169 (10·7) 3443 (12·0)
Site of first registered BCC or cSCC
Lip (cutaneous) 1491 (1·0) 3219 (2·6) 815 (1·7) 679 (2·4)
Eyelid incl. canthus 6353 (4·4) 8019 (6·5) 584 (1·2) 483 (1·7)
Ear 9439 (6·5) 1568 (1·3) 7601 (15·8) 363 (1·3)
Face 55 213 (38·2) 50 691 (40·9) 13 126 (27·2) 9308 (32·4)
Scalp/neck 11 315 (7·8) 8265 (6·7) 11 566 (24·0) 1669 (5·8)
Trunk incl. perianal 22 630 (15·6) 14 484 (11·7) 3080 (6·4) 2201 (7·7)
Upper limb incl. shoulder 9870 (6·8) 7479 (6·0) 6947 (14·4) 5416 (18·9)
Lower limb incl. hip 5637 (3·9) 10 951 (8·8) 2367 (4·9) 7205 (25·1)
Skin NOS 22 732 (15·7) 19 209 (15·5) 2168 (4·5) 1399 (4·9)

Data are n (%) unless otherwise specified. BCC, basal cell carcinoma; CI, confidence interval; cSCC, cutaneous squamous cell carcinoma; IQR, interquartile range; NOS, not otherwise specified